Minimum 20 minute delay
5/13/2013 4:01:40 PMDUBLIN--(BUSINESS WIRE)--May. 13, 2013-- Covidien plc (NYSE: COV) today announced that its wholly-owned subsidiary, Covidien International Finance S.A. (CIFSA), priced an underwritten offering of $750 million aggregate principal amount of 2.950% senior notes due 2023. The offering is expected to close on …
5/13/2013 9:00:00 AMDUBLIN--(BUSINESS WIRE)--May. 13, 2013-- Covidien plc (NYSE: COV) today announced that its wholly-owned subsidiary, Covidien International Finance S.A. (CIFSA), launched an underwritten offering of senior notes. These notes will be fully and unconditionally guaranteed on a senior unsecured basis by …
5/8/2013 7:00:39 AMMANSFIELD, Mass.--(BUSINESS WIRE)--May. 8, 2013-- Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas, NV, on Wednesday, May 15, 2013. Bryan Hanson…
5/6/2013 9:00:00 AMDUBLIN--(BUSINESS WIRE)--May. 6, 2013-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the appointment of Jacqueline Strayer as Senior Vice President, Corporate Communications, effective immediately. She will report to José E. Almeida, Chairman, President and CEO and be located in …
A Partner in Health
Collaborating with physicians and other healthcare professionals, focusing on research and development and maintaining clinical leadership add up to innovative medical solutions that make a difference.
Ensuring ethical interactions with healthcare professionals is vital to the global healthcare environment. Covidien’s Conscientious Collaboration platform is our commitment to open communications about the need to ensure compliant interactions with our customers and partners.
One look. One Covidien. Experience the new unified look of Covidien. Easy-to-use labeling. New outside packaging with the same quality products inside. First-class service and support.